(Q44793011)

English

Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study

scientific article published in March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study (English)

1 reference

Europe PubMed Central

6 December 2017

Joshua Barzilay

1

object named as

Joshua I Barzilay

0 references

2

0 references

Karen L. Margolis

4

0 references

Thomas B Wiegmann

10

object named as

Thomas Wiegmann

1 reference

Europe PubMed Central

6 December 2017

5

object named as

David C Goff

1 reference

Europe PubMed Central

6 December 2017

author name string

Judy Bettencourt

3

1 reference

Europe PubMed Central

6 December 2017

Henry Black

6

1 reference

Europe PubMed Central

6 December 2017

Gabriel Habib

7

1 reference

Europe PubMed Central

6 December 2017

Allan Ellsworth

8

1 reference

Europe PubMed Central

6 December 2017

Rex W Force

9

1 reference

Europe PubMed Central

6 December 2017

Jerry O Ciocon

11

1 reference

Europe PubMed Central

6 December 2017

Jan N Basile

12

1 reference

Europe PubMed Central

6 December 2017

ALLHAT Collaborative Research Group

13

1 reference

Europe PubMed Central

6 December 2017

publication date

1 March 2004

1 reference

Europe PubMed Central

6 December 2017

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

6 December 2017

6

1 reference

Europe PubMed Central

6 December 2017

3

1 reference

Europe PubMed Central

6 December 2017

116-125

1 reference

Europe PubMed Central

6 December 2017

Are different hemodynamic patterns of antihypertensive drugs clinically important?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03216.X

21 January 2018

Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03216.X

21 January 2018

The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03216.X

21 January 2018

Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03216.X

21 January 2018

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03216.X

21 January 2018

Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03216.X

21 January 2018

Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03216.X

21 January 2018

Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treat

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03216.X

21 January 2018

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03216.X

21 January 2018

Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03216.X

21 January 2018

Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03216.X

21 January 2018

Identifiers

10.1111/J.1524-6175.2004.03216.X

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44793011&oldid=2093296517"